Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Nutr Rev ; 67(4): 188-205, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19335713

ABSTRACT

Dietary fiber intake provides many health benefits. However, average fiber intakes for US children and adults are less than half of the recommended levels. Individuals with high intakes of dietary fiber appear to be at significantly lower risk for developing coronary heart disease, stroke, hypertension, diabetes, obesity, and certain gastrointestinal diseases. Increasing fiber intake lowers blood pressure and serum cholesterol levels. Increased intake of soluble fiber improves glycemia and insulin sensitivity in non-diabetic and diabetic individuals. Fiber supplementation in obese individuals significantly enhances weight loss. Increased fiber intake benefits a number of gastrointestinal disorders including the following: gastroesophageal reflux disease, duodenal ulcer, diverticulitis, constipation, and hemorrhoids. Prebiotic fibers appear to enhance immune function. Dietary fiber intake provides similar benefits for children as for adults. The recommended dietary fiber intakes for children and adults are 14 g/1000 kcal. More effective communication and consumer education is required to enhance fiber consumption from foods or supplements.


Subject(s)
Cardiovascular Diseases/prevention & control , Diabetes Mellitus/prevention & control , Dietary Fiber , Gastrointestinal Diseases/prevention & control , Obesity/prevention & control , Health Promotion/methods , Humans , Randomized Controlled Trials as Topic , United States
2.
Arch Intern Med ; 165(10): 1161-6, 2005 May 23.
Article in English | MEDLINE | ID: mdl-15911730

ABSTRACT

BACKGROUND: Soluble fiber supplements are recommended to reduce levels of low-density lipoprotein cholesterol (LDL-C). We evaluated the LDL-C-lowering effect of psyllium husk added to low-dose simvastatin therapy. METHODS: In a 12-week blinded placebo-controlled study, patients were randomized to receive 20 mg of simvastatin plus placebo, 10 mg of simvastatin plus placebo, or 10 mg of simvastatin plus 15 g of psyllium (Metamucil) daily. Levels of total cholesterol, LDL-C, high-density lipoprotein cholesterol, triglycerides, and apolipoprotein B were determined after 4 and 8 weeks of treatment. RESULTS: The study group comprised 68 patients. All treatments were well tolerated, and after 8 weeks the mean LDL-C levels in the group receiving 10 mg of simvastatin plus placebo fell by 55 mg/dL (1.42 mmol/L) from baseline, compared with 63 mg/dL (1.63 mmol/L) in the group receiving 10 mg of simvastatin plus psyllium (P = .03). The mean lowering of LDL-C in the group receiving 20 mg of simvastatin plus placebo was the same as that in the group receiving 10 mg of simvastatin plus psyllium. Similar results were seen for apolipoprotein B and total cholesterol. No significant changes from baseline triglyceride or high-density lipoprotein cholesterol levels occurred. CONCLUSIONS: Dietary psyllium supplementation in patients taking 10 mg of simvastatin is as effective in lowering cholesterol as 20 mg of simvastatin alone. Psyllium soluble fiber should be considered as a safe and well-tolerated dietary supplement option to enhance LDL-C and apolipoprotein B lowering.


Subject(s)
Anticholesteremic Agents/therapeutic use , Cathartics/therapeutic use , Cholesterol/blood , Hypercholesterolemia/drug therapy , Psyllium/therapeutic use , Simvastatin/therapeutic use , Adolescent , Adult , Aged , Aged, 80 and over , Apolipoproteins B/blood , Double-Blind Method , Drug Therapy, Combination , Female , Follow-Up Studies , Humans , Hypercholesterolemia/blood , Male , Middle Aged , Nephelometry and Turbidimetry , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...